Lumida
/MMS
⌘K
Maximus Inc

Maximus Inc

MMS
$56.92USD+0.69%+0.39 today

MARKET CAP

3.0B

P/E (TTM)

7.3x

FWD P/E

6.8x

DAY RANGE

$56 – $57

52W RANGE

$53
$100

AI Summary

Stalk
StalkMedium

MMS shows a post-capitulation base with selling exhaustion, but remains under the 9/20/50-day EMAs in a long-term downtrend. Medium-term bias is bullish under mean-reversion eligibility, yet price must clear and hold above the EMA cluster (~57.5–58.0) for a reliable setup. Free cash flow yield and buyback strategy support patience; deferred execution (Stalk) until reclaim and acceptance of key resistances.

  • Trades at 6.2x forward P/E near multiyear low, implying ~49% undervaluation.
  • Q3 adj. EBITDA margin reached 15.0% on efficiency and AI cost savings.
  • FY26 revenue guidance at $5.2–5.35B vs $5.43B in FY25 signals slowing top-line.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Maximus Inc. (NYSE:MMS) is a leading provider of technology-driven solutions for government agencies, operating predominantly in the healthcare and social services sectors. The company is well-positioned within the public sector services space, focusing on improving the delivery of programs and services that enhance health outcomes and ensure compliance. Currently experiencing pressures from various macroeconomic factors and operational challenges, Maximus's service offerings are crucial as governments seek efficiencies in service delivery, especially with the growing incorporation of AI-enabled tools and digital solutions.

Bull says

  • Trades at 6.2x forward P/E near multiyear low, implying ~49% undervaluation.
  • Q3 adj. EBITDA margin reached 15.0% on efficiency and AI cost savings.
  • $50.4M buybacks last quarter and 0.4% dividend yield sustain capital return.
  • FY26 guidance of $5.2–5.35B revenues; analysts expect 14.9% EPS growth in FY27.
  • $730M revolver capacity and 2.0x net leverage support financial flexibility.
  • Strong earnings yield and dividend yield; low volatility suggests stability.

Bear says

  • FY26 revenue guidance at $5.2–5.35B vs $5.43B in FY25 signals slowing top-line.
  • Weak growth outlook and consistent downward earnings revisions erode confidence.
  • Trailing book-to-bill of 0.5x reflects procurement delays and contract lag.
  • Stock down 35.6% YTD and poor momentum indicate bearish investor stance.
  • Low 13F ownership points to lack of large investor interest.
  • Weak growth and negative momentum factors undermine valuation and prospects.

Investment themes with MMS

High Dividend Yield -0.51%

Companies paying above-average dividends

AVGO · JPM · XOM
Buybacks -0.29%

Companies repurchasing their own shares

C · JCI · WFC

Earnings Call · Q2 2024 · Mgmt. Guidance

Updated 05-09-2025bullish

Transcript signals

Bull points

  • Our second quarter results were exceptionally strong, driving the second consecutive raise to our fiscal 2024 guidance.
  • Demand remains high across our programs, which elevated volumes this quarter and perhaps more importantly is indicative of stability returning following the disruptive years of the pandemic.
  • We are also acutely focused on cost management, which had a positive impact to this quarter and has added potential to further improve our bottom line in future periods.
Read full transcript analysis ›